U.S. FDA likely to authorize COVID-19 vaccine for kids based on two months of safety data
U.S.
heath regulators said children in clinical trials testing COVID-19
vaccines should be monitored for at least two months for side effects,
suggesting that the agency is considering a quicker path to authorize
the...read more.
Comments
Post a Comment